Latest filing published 25 Sept 2026 for Eupraxia Pharmaceuticals Inc..
Joseph Stuart Freedman filed 12 open-market purchases, for EUR 235,943 with a median of EUR 17,212, and no sale. The three largest are bunched in late May 2020 at Bridgemarq Real Estate Services Inc.: EUR 48,220 on May 21, EUR 35,195 on May 19 and EUR 23,889 on May 22.
Two issuers appear. At Eupraxia Pharmaceuticals Inc., Joseph Stuart Freedman is a director (30 filings, 8 purchases); at Bridgemarq, the filing is made on behalf of a significant security holder (7 filings, 4 purchases). The record also holds 2 grants and 23 filings of another nature, 37 in all.
The calendar fits in three years: 5 filings in 2020, 18 in 2025 and 14 in 2026. The 15 filings of the last twelve months include no purchase and no sale. Freedman has 4, 4 and 4 own market trades within 30 days of colleagues at Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.), in that order. All on the same side. Names in order: Gail Susan Kilgour, Glen McMillan and Philip Dewey Kenneth Soper.
For the 12 purchases, the stored 90-day result has a median of 38.3%, all positive (stored past results, not a forecast).
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 60 declarations